Article

Multicentre trial evaluating alveolar NO fraction as a marker of asthma control and severity

Cabinet La Berma, Antony, France.
Allergy (Impact Factor: 6). 10/2009; 65(5):636-44. DOI: 10.1111/j.1398-9995.2009.02221.x
Source: PubMed

ABSTRACT Exhaled NO can be partitioned in its bronchial and alveolar sources, and the latter may increase in the presence of recent asthmatic symptoms and in refractory asthma. The aim of this multicentre prospective study was to assess whether alveolar NO fraction and FE(NO) could be associated with the level of asthma control and severity both at the time of measurement and in the subsequent 3 months.
Asthma patients older than 10 years, nonsmokers, without recent exacerbation and under regular treatment, underwent exhaled NO measurement at multiple constant flows allowing its partition in alveolar (with correction for back-diffusion) and bronchial origins based on a two-compartment model of NO exchange; exhaled NO fraction at 50 ml/s (FE(NO,0.05)) was also recorded. On inclusion, severity was assessed using the four Global initiative for asthma (GINA) classes and control using Asthma Control Questionnaire (ACQ). Participants were followed-up for 12 weeks, control being assessed by short-ACQ on 1st, 4th, 8th and 12th week.
Two-hundred patients [107 children and 93 adults, median age (25th; 75th percentile) 16 years (12; 38)], 165 receiving inhaled corticosteroid, were included in five centres. The two-compartment model was valid in 175/200 patients (87.5%). Alveolar NO and FE(NO,0.05) did not correlate to control on inclusion or follow-up (either with ACQ /short-ACQ values or their changes), nor was influenced by severity classes. Alveolar NO negatively correlated to MEF(25-75%) (rho = -0.22, P < 0.01).
Alveolar and exhaled NO fractions are not indexes of control or severity in asthmatic children and adults under treatment.

Download full-text

Full-text

Available from: André Denjean, Jul 06, 2015
1 Follower
 · 
133 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Asthma control, evaluated by symptoms, exacerbations rate and lung function may be greatly influenced by comorbidities, particularly chronic rhinosinusitis (CRS). Measurement of nasal nitric oxide (nNO) is a simple way to assess the severity of CRS. We aimed to analyze the relationship between asthma control and nasal NO. All patients with moderate-to-severe asthma on regular follow-up at our Outpatients' Clinic between November 2009 and April 2010 were included into the study. All patients were evaluated for asthma control by asthma control questionnaire (ACQ) and comorbidities (rhinitis, chronic rhinosinusitis with (CRSwNP) or without nasal polyps, obesity). Exhaled nitric oxide and nNO were obtained in all patients. Eighty-two patients were enrolled (mean age: 48 years, range: 21-80; 42 females). According to ACQ, 53 patients (64.6%) reported controlled asthma. Patients with uncontrolled asthma had lower nNO and higher prevalence of CRSwNP, with a significant correlation between nNO and ACQ. nNO is a biomarker negatively related to asthma control. As low nNO values were associated to CRSwNP, our results indicate that asthma control is highly influenced by this comorbidity.
    Journal of Breath Research 05/2013; 7(2):026009. DOI:10.1088/1752-7155/7/2/026009 · 3.59 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Chronic inflammation in asthma is a key feature of the disease and monitoring is an essential component of asthma management. Inflammation is present in both central and peripheral bronchi and can be measured by non invasive markers, such as fractional exhaled nitric oxide (FeNO). FeNO is increased in asthmatics, as compared to normal subjects and is lowered by inhaled corticosteroids (ICS) with a dose-response relationship that is more evident for asthmatic patients with high levels of FeNO. FeNO measuring is easy to be performed in almost all patients including children and can be helpful as a tool contributing to asthma diagnosis and evaluation of the response to antinflammatory therapy with ICS. Smoking affects FeNO measurements and this has to be considered when evaluating patients with asthma who smoke. The different measurement of bronchial and alveolar FeNO can give information on the distribution of inflammation in the bronchial tree and is of particular interest for clinical pharmacology. Nonetheless, the clinical application of FeNO still needs to be clarified but it is clearly nowadays one of the most used non-invasive markers giving information on the inflammatory component of the disease.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The measurement of the velocity and power flow angle of surface acoustic waves (SAWS) using a scanning laser acoustic microscope is described. Data obtained from a single scan by the microscope and from a single direction of insonification is Fourier transformed from the spatial domain into the spatial frequency domain. The incident cw surface waves scatter from the s ides of the sample into all possible wavevectors. Thus, the Fourier transform in the spatial frequency domain is the inverse velocity or slowness curve for surface waves propagaging on the material. From this curve, the phase velocity, group velocity, and power flow angle versus propagation direction can be obtained. Experimental results for YZ lithium niobate, ST quartz, and (111) silicon are in good agreement w i t h the o ret i ca 1 c a1 cu 1 at i on s.